Molecular Blood Group Diagnostics

Serological methods reach their limits when it comes to the determination of rare blood group characteristics. Therefore, it is difficult to identify blood donors with rare blood types who are needed for patients with pre-formed antibodies.

Molecular blood group typing enables a safe on-demand supply of blood preservations for patients with antibodies against clinical relevant, weak or rare blood group antigens.

The molecular determination of rare antigens can be applied on-demand and to pre-typing of blood donors. Pre-typing of blood donors has the advantages to increase the patient´s safety and to reduce your effort and your costs.

In addition, due to its molecular based technology it makes you independent of antisera for rare antigens which are often difficult to obtain and suboptimal in quality.

Fast and gel-free weak D determination

ERY Q^® is optimally suited for blood group determination in case of serologically discrepant or doubtful Rhesus D antigen determinations. The PCR kit convinces as a molecular genetic real-time test with easy handling in only one PCR mix.

As a detection system especially for the Weak D types 1, 2 and 3, with the exclusion of Weak D type 1.1, we offer with Weak D-TYPE 1-2-3 Q the "small" perfectly fitting variant.

Due to the liquid format, the kits are extremely flexible to use, as they are compatible with most commercially available real-time cyclers. Dilution of the DNAs is usually not necessary, as valid results are obtained in a wide range of DNA concentrations.

Increase safety in blood group diagnostics

The determination of clinical relevant, weak or rare variants of blood group systems on a molecular genetic basis gives you a higher safety in the diagnosis of blood donors, recipients, patients and pregnant women. BAG offers easy-to-use test kits in a modular concept that enables an effective handling of all your requirements.